All Type of News
Multinational pharmaceutical companies betting everything on development of new drugs
While growth of multinational pharmaceutical companies in the domestic market has lost in speed, they tend to focus on development of new drugs.
One of the outstanding companies in the trend is MSD Korea. Last year, ...
43 pharmaceutical distribution companies recording over KRW 100 billion sales in a year
It is known that there were the total 43 pharmaceutical distribution companies recording KRW 100 billion sales last year. Moreover, it is analyzed that 9 pharmaceutical distribution companies with over KRW 300 billion...
The annual wage of employees in multinational pharmaceutical companies exceeds KRW 70 million in average
It is observed that the average annual wage of employees working in Korean branches of multinational pharmaceutical companies were over KRW 70 million and ones in UBC Korea recorded the highest annual wage with approx...
A half of domestic M&A cases are made between pharmaceutical companies
It is observed that M&As among pharmaceutical companies are more active than other industries.
The Korea Health Industry Development Institute analyzed M&A cases of global pharmaceutical companies between 2010 and 20...
The domestic launch of the stomach cancer target agent ‘Cyramza’ is visualized
The fact that a new target agent for stomach cancer is visualized attracted the pharmaceutical industry.
According to the Ministry of Food and Drug Safety on the 15th, the Lilly Korea’s stomach cancer target agent ‘C...
The dermatological pharmaceutical company ‘Sinclair’ started the countdown to expand to the domestic marketAnother multinational pharmaceutical company specializing in dermatology is looking forward to expand to the domestic market.
According to the coverage result of Daily Pharm on...
|
28 multinational pharmaceutical companies spent 4.5%of sales and 6 spent more than KRW 10 billion
It is observed that Pfizer Korea was the company spent the most, KRW 45.471 billion on advertisements among Korean branches of multinational pharmaceutical companies entered in Korea.
Moreover, it is investigated tha...
MSD states “Keytruda is an innovative antibody that will create its own pipeline itself”The pharmaceutical industry has paid attention on the domestically first anti-PD-1 immunotherapy ‘Keytruda’.
On the 14th, MSD Korea announced that it held a press conference to...
|
GSK and SK will release competing products of the shingles vaccine ‘Zostavax’It is expected that competing products of the only herpes zoster vaccine ‘Zostavax’ will be launched.
According to the industry concerned on the 15th, a multinational company ‘...
|
The completion of domestic dementia patches and pharmaceutical technologies threats original products
“They do not make new drugs, but definitely are good at developing medicines using new substances.”
Domestic pharmaceutical companies are showing capability on developing drugs with their experience of developing gen...
